TABLE 4.
Seroprevalence of IgG and IgM anti-HEV in other liver disease controlsa
Liver disease | Patients
|
No. (%) of patients with seroprevalence for:
|
||
---|---|---|---|---|
No. | Age (yr)b | IgG anti-HEV | IgM anti-HEV | |
Acute | ||||
Hepatitis A | 26 | 30 ± 11 | 1 (3.8) | 3 (11.5) |
Hepatitis B | 27 | 35 ± 15 | 0 (0) | 0 (0) |
Hepatitis C | 27 | 49 ± 17 | 3 (11.1) | 0 (0) |
Hepatitis D | 34 | 43 ± 18 | 5 (14.7) | 0 (0) |
Chronic | ||||
Chronic hepatitis B with acute exacerbation | 36 | 46 ± 16 | 5 (14.3) | 0 (0) |
Autoimmune hepatitis | 6 | 42 ± 21 | 1 (16.7) | 0 (0) |
Primary biliary cirrhosis | 5 | 63 ± 10 | 0 (0) | 0 (0) |
All serum samples were negative for HEV RNA.
Mean ± SD.